CompuGroup Medical successfully completes share buyback program

EQS-News: CompuGroup Medical SE & Co. KGaA / Key word(s): Share Buyback
CompuGroup Medical successfully completes share buyback program

29.04.2024 / 14:49 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

CompuGroup Medical successfully completes share buyback program

* Target reached before expiration date

* Company acquires 500,000 shares

* Volume of EUR 14.6 million

Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback
program successfully on April 26 shortly before the expiration date. The
target of a maximum of 500,000 shares to be acquired was reached last
Friday. The volume acquired corresponds to approximately 0.93% of the
Company´s share capital. The company announced the start of the program on
March 25, 2024 pursuant to Art. 2 para. 1 Commission Delegated Regulation
(EU) No 2016/1052 to start on March 26, 2024.

The weighted average price per share acquired was EUR 29.26, the total
volume of the buyback was EUR 14.6 million. The general partner of CGM had
granted a volume of up to EUR 15.5 million for the buyback.

CFO Daniela Hommel said: 'We are pleased with the successful share buyback.
By acquiring own shares we are confirming our confidence in the future of
our company and are expanding our options for further strategic
development.'

The shares were purchased exclusively via the Frankfurt Stock Exchange
(XETRA trading) by a bank commissioned by CGM. The Company's own shares
acquired through the buyback program can be used for any purpose permitted
under the authorization granted by the Annual General Meeting on May 19,
2021.

Further information on the share buyback program and the upcoming virtual
Annual General Meeting on 22 May can be found on the website at
https://www.cgm.com/corp_en/company/ir-en.html.


---------------------------------------------------------------------------

29.04.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        CompuGroup Medical SE & Co. KGaA
                   Maria Trost 21
                   56070 Koblenz
                   Germany
   Phone:          +49 (0)160 3630362
   Fax:            +49 (0)261 8000 3200
   E-mail:         investor@cgm.com
   Internet:       www.cgm.com
   ISIN:           DE000A288904
   WKN:            A28890
   Indices:        SDAX, TecDAX
   Listed:         Regulated Market in Frankfurt (Prime Standard);
                   Regulated Unofficial Market in Berlin, Dusseldorf,
                   Hamburg, Munich, Stuttgart, Tradegate Exchange
   EQS News ID:    1891987

End of News EQS News Service
---------------------------------------------------------------------------

1891987 29.04.2024 CET/CEST